Canaan Partners

Investment thesis

Generalist firm with a roughly 60/40 tech-versus-healthcare split, running a transparent, debate-driven partnership. In biopharma it invests from seed through Series A with a focus on de novo company creation and being early on new targets and modalities.

Notable portfolio

Sector focus